SHW:NYSESherwin-Williams Company (The) Analysis
Data as of 2026-06-11 - not real-time
$303.91
Latest Price
6/10Risk
Risk Level: Medium
Executive Summary
Sherwin‑Williams is trading at $303.91, just above its 20‑day SMA of $303.88 and comfortably above the identified support at $289.86, while still below the 50‑day SMA of $317.40, indicating a short‑term price floor but lingering bearish bias. The RSI of 46.7 and a bullish MACD histogram (+1.13) suggest limited downside momentum and a potential technical bounce, yet volume is trending downward and the 30‑day volatility is elevated at 28%, flagging short‑term uncertainty. Fundamentally, the company delivers strong profitability with a 10.9% net margin, 49% gross margin, and an exceptional ROE of 60.7%, supported by $2.14 B of free cash flow, though its debt‑to‑equity ratio of 329% raises leverage concerns. The consensus analyst view remains positive, with a median price target of $369.5 implying ~22% upside, and the dividend yield of 1.05% is backed by a modest 30% payout ratio.
Recent developments such as the launch of a data‑center coating guide for AI‑driven facilities and inclusion in top dividend‑stock lists highlight growth avenues and shareholder appeal, while mixed analyst actions (price targets ranging $380‑$400 and a recent UBS downgrade due to housing headwinds) underscore sector‑specific risks. Overall, the stock appears undervalued relative to its earnings power and dividend profile, but investors should weigh the high leverage and sector volatility when timing entry points.
Recent developments such as the launch of a data‑center coating guide for AI‑driven facilities and inclusion in top dividend‑stock lists highlight growth avenues and shareholder appeal, while mixed analyst actions (price targets ranging $380‑$400 and a recent UBS downgrade due to housing headwinds) underscore sector‑specific risks. Overall, the stock appears undervalued relative to its earnings power and dividend profile, but investors should weigh the high leverage and sector volatility when timing entry points.
Market Outlook
Short Term
< 1 yearNeutral
Model confidence: 6/10
Key Factors
- Bearish trend direction and decreasing volume
- Price near 20‑day SMA with support intact
- Technical bullish MACD histogram but limited upside
Medium Term
1–3 yearsPositive
Model confidence: 8/10
Key Factors
- Analyst median price target of $369.5 (~22% upside)
- Strong earnings growth and high ROE
- Attractive dividend yield with sustainable payout
Long Term
> 3 yearsPositive
Model confidence: 7/10
Key Factors
- Durable franchise and expanding data‑center coating segment
- Consistent dividend growth and solid cash‑flow generation
- Undervaluation relative to long‑term earnings and peer multiples
Key Metrics & Analysis
Financial Health
Revenue Growth6.80%
Profit Margin10.86%
P/E Ratio29.9
ROE60.72%
ROA9.45%
Debt/Equity329.52
P/B Ratio16.8
Op. Cash Flow$3.7B
Free Cash Flow$2.1B
Technical Analysis
TrendBearish
RSI46.7
Support$289.86
Resistance$315.56
MA 20$303.88
MA 50$317.40
MA 200$336.18
MACDBullish
VolumeDecreasing
Fear & Greed Index81.75
Valuation
Fair Value$93.44
Target Price$372.95
Upside/Downside22.72%
GradeUndervalued
TypeBlend
Dividend Yield1.05%
Risk Assessment
Beta0.76
Volatility28.12%
Sector RiskMedium
Reg. RiskMedium
Geo RiskMedium
Currency RiskLow
Liquidity RiskMedium
Similar Tickers
This analysis may contain inaccuracies and is provided for informational and research purposes only. It is not personal investment advice, a recommendation, or an instruction to buy, sell, or hold any asset.